Literature DB >> 19167193

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.

Dong Wook Kim1, Sang Kun Lee, Kon Chu, In-Jin Jang, Kyung-Sang Yu, Joo-Youn Cho, Seon-Jeong Kim.   

Abstract

ATP-binding cassette (ABC) transporters participate in drug disposition and response in various conditions, and many polymorphisms in ABC transporter genes have been recognized in association with altered transporter functions of various drugs. Studies on epilepsy have focused on the C3435T polymorphism of the ABCB1 gene, but other ABC transporters are also thought to be involved in the transport of antiepileptic drugs. We have evaluated the functional polymorphisms of ABCB1, ABCG2, and ABCC2 genes with regard to epilepsy drug response in partial epilepsy, and have investigated the potential of combined effects of polymorphisms in more than one transporter gene. We studied 6 genetic polymorphisms in 3 transporter genes in 193 drug responders and 198 nonresponders. There was no significant difference between the two groups, and we did not observe any combined effects of ABCB1 and ABCG2 genetic polymorphisms. Our study suggests that genetic polymorphisms in ABC transporters may not be significant predictors of drug response in epilepsy patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167193     DOI: 10.1016/j.eplepsyres.2008.12.001

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  14 in total

1.  Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients.

Authors:  Mehri Maleki; Mohammad Sayyah; Fatemeh Kamgarpour; Morteza Karimipoor; Aida Arab; Anahita Rajabi; Kourosh Gharagozli; Ahmad Reza Shamshiri; Esmaeil Shahsavand Ananloo
Journal:  Iran Biomed J       Date:  2010-07

2.  Biomarkers for antiepileptic drug response.

Authors:  Tracy A Glauser
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

3.  Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis.

Authors:  Wei-Ping Lv; Ren-Feng Han; Zhi-Rong Shu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 4.  Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.

Authors:  Hisham Qosa; David S Miller; Piera Pasinelli; Davide Trotti
Journal:  Brain Res       Date:  2015-07-15       Impact factor: 3.252

Review 5.  Gene polymorphisms and their role in epilepsy treatment and prognosis.

Authors:  Ortrud K Steinlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-16       Impact factor: 3.000

Review 6.  The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.

Authors:  Pin Chen; Qing Yan; Haitao Xu; Ailin Lu; Peng Zhao
Journal:  Genet Test Mol Biomarkers       Date:  2013-12-10

7.  ABCB1 gene C3435T polymorphism and drug resistance in epilepsy: evidence based on 8,604 subjects.

Authors:  Shu-Xia Li; Yun-Yong Liu; Quan-Bao Wang
Journal:  Med Sci Monit       Date:  2015-03-23

8.  Association of ABCB1 gene polymorphism (C1236T and C3435T) with refractory epilepsy in Iraqi patients.

Authors:  Khalid S Salih; Farqad B Hamdan; Qasim S Al-Mayah; Akram M Al-Mahdawi
Journal:  Mol Biol Rep       Date:  2020-05-27       Impact factor: 2.316

9.  Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital.

Authors:  Soobitha Subenthiran; Noor Rain Abdullah; Joyce Pauline Joseph; Prem Kumar Muniandy; Boon Teck Mok; Chee Cheong Kee; Zakiah Ismail; Zahurin Mohamed
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

10.  Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance.

Authors:  Shabeesh Balan; Sumitha Prameela Bharathan; Neetha Nanoth Vellichiramal; Sanish Sathyan; Vijai Joseph; Kurupath Radhakrishnan; Moinak Banerjee
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.